{"id":2436,"date":"2019-05-10T15:53:25","date_gmt":"2019-05-10T19:53:25","guid":{"rendered":"https:\/\/www.frontagelab.com\/?page_id=2436"},"modified":"2020-11-12T14:09:39","modified_gmt":"2020-11-12T19:09:39","slug":"announcements-and-circulars","status":"publish","type":"page","link":"https:\/\/frontagelab.com.cn\/en\/investor-relations\/announcements-and-circulars\/","title":{"rendered":"Announcements and Circulars"},"content":{"rendered":"\n

Date<\/td>Title<\/td><\/td><\/tr>
2025.01.06<\/td>CHANGE OF CHIEF EXECUTIVE OFFICER<\/td><\/i><\/a><\/td><\/tr>
2024.12.13<\/td>CHANGE OF ADDRESS OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG<\/td><\/i><\/a><\/td><\/tr>
2025.01.06<\/td>CHANGE OF CHIEF EXECUTIVE OFFICER<\/td><\/i><\/a><\/td><\/tr>
2024.12.13<\/td>CHANGE OF ADDRESS OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG<\/td><\/i><\/a><\/td><\/tr>
2024.10.30<\/td>GRANT OF SHARE OPTIONS<\/td><\/i><\/a><\/td><\/tr>
2024.10.29<\/td>ANNOUNCEMENT UNAUDITED FINANCIAL INFORMATION FOR THE THIRD QUARTER OF 2024<\/td><\/i><\/a><\/td><\/tr>
2024.09.20<\/td>Notification Letter and Request Form For Non-Registered Holders<\/td><\/i><\/a><\/td><\/tr>
2024.09.20<\/td>Notification Letter and Reply Form For Registered Holders<\/td><\/i><\/a><\/td><\/tr>
2024.09.09<\/td>SUPPLEMENTAL ANNOUNCEMENT - RENEWAL OF SERVICES FRAMEWORK AGREEMENT<\/td><\/i><\/a><\/td><\/tr>
2024.08.28<\/td>RENEWAL OF SERVICES FRAMEWORK AGREEMENT<\/td><\/i><\/a><\/td><\/tr>
2024.08.28<\/td>ANNOUNCEMENT ON INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2024<\/td><\/i><\/a><\/td><\/tr>
2024.08.15<\/td>DATE OF BOARD MEETING<\/td><\/i><\/a><\/td><\/tr>
2024.05.28<\/td>POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON MAY 28, 2024<\/td><\/i><\/a><\/td><\/tr>
2024.04.25<\/td>ANNOUNCEMENT UNAUDITED FINANCIAL INFORMATION FOR THE FIRST QUARTER OF 2024<\/td><\/i><\/a><\/td><\/tr>
2024.04.23<\/td>Notification Letter to Non-Registered Shareholders<\/td><\/i><\/a><\/td><\/tr>
2024.04.23<\/td>Notification Letter to Registered Shareholders and Reply Form<\/td><\/i><\/a><\/td><\/tr>
2024.04.23<\/td>PROXY FORMS<\/td><\/i><\/a><\/td><\/tr>
2024.04.23<\/td>NOTICE OF ANNUAL GENERAL MEETING<\/td><\/i><\/a><\/td><\/tr>
2024.04.23<\/td>CIRCULAR OF ANNUAL GENERAL MEETING<\/td><\/i><\/a><\/td><\/tr>
2024.03.28<\/td>ANNOUNCEMENT ON ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2023<\/td><\/i><\/a><\/td><\/tr>
2024.03.15<\/td>DATE OF BOARD MEETING<\/td><\/i><\/a><\/td><\/tr>
2024.01.31<\/td>CHANGE OF CHIEF FINANCIAL OFFICER<\/td><\/i><\/a><\/td><\/tr>
2024.01.28<\/td>UNUSUAL PRICE AND TRADING VOLUME MOVEMENT<\/td><\/i><\/a><\/td><\/tr>
2024.01.12<\/td>Dissemination of Corporate Communications<\/td><\/i><\/a><\/td><\/tr>
2024.01.12<\/td>Letter to Shareholders \u2013 Election of Language and Means of Receipt of Corporate Communications<\/td><\/i><\/a><\/td><\/tr>
2023.12.20<\/td>GRANT OF SHARE OPTIONS<\/td><\/i><\/a><\/td><\/tr>
2023.10.27<\/td>VOLUNTARY ANNOUNCEMENT - SHARE REPURCHASE PLAN<\/td><\/i><\/a><\/td><\/tr>
2023.08.25<\/td>ANNOUNCEMENT ON INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2023<\/td><\/i><\/a><\/td><\/tr>
2023.08.25<\/td>REVISION OF ANNUAL CAPS IN RELATION TO THE RENEWED SERVICES FRAMEWORK AGREEMENT<\/td><\/i><\/a><\/td><\/tr>
2023.08.16<\/td>DISCLOSEABLE TRANSACTION-ACQUISITION OF 100% EQUITY INTEREST IN NUCRO TECHNICS INC. & NUCRO-TECHNICS HOLDINGS, INC.<\/td><\/i><\/a><\/td><\/tr>
2023.08.11<\/td>DATE OF BOARD MEETING<\/td><\/i><\/a><\/td><\/tr>
2023.08.10<\/td>SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE 2022 ANNUAL REPORT<\/td><\/i><\/a><\/td><\/tr>
2023.05.25<\/td>SECOND AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION<\/td><\/i><\/a><\/td><\/tr>
2023.05.25<\/td>POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON MAY 25, 2023<\/td><\/i><\/a><\/td><\/tr>
2023.04.25<\/td>ANNOUNCEMENT UNAUDITED FINANCIAL INFORMATION FOR THE FIRST QUARTER OF 2023<\/td><\/i><\/a><\/td><\/tr>
2023.04.20<\/td>PROXY FORMS<\/td><\/i><\/a><\/td><\/tr>
2023.04.20<\/td>NOTICE OF ANNUAL GENERAL MEETING<\/td><\/i><\/a><\/td><\/tr>
2023.04.20<\/td>CIRCULAR OF ANNUAL GENERAL MEETING<\/td><\/i><\/a><\/td><\/tr>
2023.03.28<\/td>ANNOUNCEMENT ON ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2022<\/td><\/i><\/a><\/td><\/tr>
2023.03.28<\/td>PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION<\/td><\/i><\/a><\/td><\/tr>
2023.03.15<\/td>DATE OF BOARD MEETING<\/td><\/i><\/a><\/td><\/tr>
2023.03.06<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 28 February 2023<\/td><\/i><\/a><\/td><\/tr>
2023.02.03<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 January 2023<\/td><\/i><\/a><\/td><\/tr>
2023.01.05<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 December 2022<\/td><\/i><\/a><\/td><\/tr>
2023.01.03<\/td>LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS<\/td><\/i><\/a><\/td><\/tr>
2023.01.03<\/td>CHANGE OF CHIEF EXECUTIVE OFFICER<\/td><\/i><\/a><\/td><\/tr>
2022.12.30<\/td>Terms of Reference of the Remuneration Committee<\/td><\/i><\/a><\/td><\/tr>
2022.12.06<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 November 2022<\/td><\/i><\/a><\/td><\/tr>
2022.11.04<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2022<\/td><\/i><\/a><\/td><\/tr>
2022.10.25<\/td>ANNOUNCEMENT UNAUDITED FINANCIAL INFORMATION FOR THE THIRD QUARTER OF 2022<\/td><\/i><\/a><\/td><\/tr>
2022.10.11<\/td>GRANT OF SHARE OPTIONS CLARIFICATION ANNOUNCEMENT<\/td><\/i><\/a><\/td><\/tr>
2022.10.07<\/td>GRANT OF SHARE OPTIONS<\/td><\/i><\/a><\/td><\/tr>
2022.10.06<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2022<\/td><\/i><\/a><\/td><\/tr>
2022.09.05<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 August 2022<\/td><\/i><\/a><\/td><\/tr>
2022.08.25<\/td>ANNOUNCEMENT ON INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2022<\/td><\/i><\/a><\/td><\/tr>
2022.08.15<\/td>CHANGE OF ADDRESS OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG AND CHANGE OF ADDRESS OF HONG KONG BRANCH SHARE REGISTRAR AND TRANSFER OFFICE<\/td><\/i><\/a><\/td><\/tr>
2022.08.12<\/td>DATE OF BOARD MEETING<\/td><\/i><\/a><\/td><\/tr>
2022.08.04<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 July 2022<\/td><\/i><\/a><\/td><\/tr>
2022.08.02<\/td>SUPPLEMENTAL ANNOUNCEMENT - CONNECTED TRANSACTION - ACQUISITION OF FRONTAGE CLINICAL SERVICES, INC.<\/td><\/i><\/a><\/td><\/tr>
2022.07.28<\/td>CONNECTED TRANSACTION - ACQUISITION OF FRONTAGE CLINICAL SERVICES, INC.<\/td><\/i><\/a><\/td><\/tr>
2022.07.08<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 June 2022<\/td><\/i><\/a><\/td><\/tr>
2022.07.06<\/td>LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS<\/td><\/i><\/a><\/td><\/tr>
2022.07.06<\/td>REDESIGNATION OF A DIRECTOR<\/td><\/i><\/a><\/td><\/tr>
2022.06.02<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended May 31, 2022<\/td><\/i><\/a><\/td><\/tr>
2022.06.01<\/td>LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS<\/td><\/i><\/a><\/td><\/tr>
2022.06.01<\/td>(1) RESIGNATION OF NON-EXECUTIVE DIRECTOR (2) APPOINTMENT OF NON-EXECUTIVE DIRECTORS, CHANGE IN COMPOSITION OF AUDIT AND RISK MANAGEMENT COMMITTEE AND (3) CHANGE OF AUTHORISED REPRESENTATIVE<\/td><\/i><\/a><\/td><\/tr>
2022.05.31<\/td>Notification Letter - Notice of Publication of Environmental, Social and Governance Report 2021 of the Company<\/td><\/i><\/a><\/td><\/tr>
2022.05.27<\/td>POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON MAY 26, 2022<\/td><\/i><\/a><\/td><\/tr>
2022.05.17<\/td>SPECIAL ARRANGEMENTS FOR THE ANNUAL GENERAL MEETING TO BE HELD ON MAY 26, 2022<\/td><\/i><\/a><\/td><\/tr>
2022.05.12<\/td>CHANGE OF VENUE AND TIME OF ANNUAL GENERAL MEETING TO BE HELD ON MAY 26, 2022<\/td><\/i><\/a><\/td><\/tr>
2022.05.06<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended April 30, 2022<\/td><\/i><\/a><\/td><\/tr>
2022.04.26<\/td>UNAUDITED FINANCIAL INFORMATION FOR THE FIRST QUARTER OF 2022<\/td><\/i><\/a><\/td><\/tr>
2022.04.21<\/td>PROXY FORM<\/td><\/i><\/a><\/td><\/tr>
2022.04.21<\/td>NOTICE OF ANNUAL GENERAL MEETING<\/td><\/i><\/a><\/td><\/tr>
2022.04.21<\/td>CIRCULAR OF ANNUAL GENERAL MEETING<\/td><\/i><\/a><\/td><\/tr>
2022.04.07<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended March 31, 2022<\/td><\/i><\/a><\/td><\/tr>
2022.03.28<\/td>ANNOUNCEMENT ON ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2021<\/td><\/i><\/a><\/td><\/tr>
2022.03.15<\/td>Date of Board Meeting<\/td><\/i><\/a><\/td><\/tr>
2022.03.04<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended February 28, 2022<\/td><\/i><\/a><\/td><\/tr>
2022.02.09<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended January 31, 2022<\/td><\/i><\/a><\/td><\/tr>
2022.01.19<\/td>Next Day Disclosure Return<\/td><\/i><\/a><\/td><\/tr>
2022.01.11<\/td>CLOSING OF DISCLOSEABLE TRANSACTION-ACQUISITION OF 100% OF THE MEMBERSHIP INTERESTS IN EXPERIMUR LLC, EXPERIMUR INTERMEDIATE LLC & EXPERIMUR PROPERTIES LLC<\/td><\/i><\/a><\/td><\/tr>
2022.01.06<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended December 31, 2021<\/td><\/i><\/a><\/td><\/tr>
2021.12.30<\/td>DISCLOSEABLE TRANSACTION-ACQUISITION OF 100% OF THE MEMBERSHIP INTERESTS IN EXPERIMUR LLC, EXPERIMUR INTERMEDIATE LLC & EXPERIMUR PROPERTIES LLC<\/td><\/i><\/a><\/td><\/tr>
2021.12.06<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended November 30, 2021<\/td><\/i><\/a><\/td><\/tr>
2021.11.04<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended October 31, 2021<\/td><\/i><\/a><\/td><\/tr>
2021.10.07<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended September 30, 2021<\/td><\/i><\/a><\/td><\/tr>
2021.09.06<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended August 31, 2021<\/td><\/i><\/a><\/td><\/tr>
2021.08.25<\/td>Announcement on Interim Results for the Six Months Ended June 30, 2021<\/td><\/i><\/a><\/td><\/tr>
2021.08.11<\/td>Date of Board Meeting<\/td><\/i><\/a><\/td><\/tr>
2021.08.05<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended July 31, 2021<\/td><\/i><\/a><\/td><\/tr>
2021.08.02<\/td>Positive Profit Alert<\/td><\/i><\/a><\/td><\/tr>
2021.07.29<\/td>Closing of Disclosable Transaction - Acquisition of 100% Equity Interest in Quintara Discovery, Inc.<\/td><\/i><\/a><\/td><\/tr>
2021.07.09<\/td>2020 Environmental, Social and Governance Report <\/td><\/i><\/a><\/td><\/tr>
2021.07.09<\/td>(Revised) Monthly Return of Equity Issuer on Movements in Securities for the Month Ended June 30, 2021 <\/td><\/i><\/a><\/td><\/tr>
2021.07.09 <\/td>(Revised) Monthly Return of Equity Issuer on Movements in Securities for the Month Ended May 31, 2021 <\/td><\/i><\/a><\/td><\/tr>
2021.0707<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended June 30, 2021 <\/td><\/i><\/a><\/td><\/tr>
2021.06.28<\/td>Acquisition of 100% Equity Interest in Quintara Discovery, Inc.<\/td><\/i><\/a><\/td><\/tr>
2021.06.04<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended May 31, 2021<\/td><\/i><\/a><\/td><\/tr>
2021.05.27<\/td>Poll Results of the Annual General Meeting held on May 27, 2021<\/td><\/i><\/a><\/td><\/tr>
2021.05.06<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended April 30, 2021<\/td><\/i><\/a><\/td><\/tr>
2021.04.28<\/td>Revise Proxy Form<\/td><\/i><\/a><\/td><\/tr>
2021.04.28<\/td>Clarification annoucement<\/td><\/i><\/a><\/td><\/tr>
2021.04.23<\/td>Proxy form <\/td><\/i><\/a><\/td><\/tr>
2021.04.23<\/td>(1) PROPOSED RE-ELECTION OF DIRECTORS (2) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND ISSUE SHARES (3) PROPOSED GRANTING OF ANNUAL MANDATE UNDER THE 2018 SHARE INCENTIVE PLAN (4) CONNECTED TRANSACTION INVOLVING THE GRANT, ALLOTMENT AND ISSUE OF NEW SHARES TO CONNECTED PERSONS UNDER THE 2021 SHARE AWARD SCHEME PURSUANT TO SPECIFIC MANDATE AND (5) NOTICE OF ANNUAL GENERAL MEETING<\/td><\/i><\/a><\/td><\/tr>
2021.04.23<\/td>Notice of AGM <\/td><\/i><\/a><\/td><\/tr>
2021.03.29<\/td>Announcement On Annual Results For The Year Ended December 31, 2020<\/td><\/i><\/a><\/td><\/tr>
2021.03.16<\/td>Date Of Board Meeting<\/td><\/i><\/a><\/td><\/tr>
2021.03.04<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended February 28, 2021<\/td><\/i><\/a><\/td><\/tr>
2021.02.11<\/td>Supplemental Announcement<\/td><\/i><\/a><\/td><\/tr>
2021.02.10<\/td>List of Directors and Their Roles and Functions<\/td><\/i><\/a><\/td><\/tr>
2021.02.10<\/td>Appointment of Executive Director and Change of Chairman and Chief Executive Officer<\/td><\/i><\/a><\/td><\/tr>
2021.02.05<\/td>Supplemental Announcement in relation to the Connected Transaction involving grant of Awarded Shares to Connected Persons under the 2021 Share Award Scheme<\/td><\/i><\/a><\/td><\/tr>
2021.02.04<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended January 31, 2021 <\/td><\/i><\/a><\/td><\/tr>
2021.01.26<\/td>(1) Grant Of Awarded Shares Pursuant To The 2021 Share Award Scheme; And (2) Connected Transaction Involving Grant Of Awarded Shares To Connected Persons Under The 2021 Share Award Scheme\u00a0 <\/td><\/i><\/a><\/td><\/tr>
2021.01.22<\/td>Adoption Of 2021 Share Award Scheme<\/td><\/i><\/a><\/td><\/tr>
2021.01.06<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended\u00a0December 31, 2020\u00a0 <\/td><\/i><\/a><\/td><\/tr>
2020.12.04<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended\u00a0November 30, 2020\u00a0 <\/td><\/i><\/a><\/td><\/tr>
2020.11.25<\/td>Change Of Auditor<\/td><\/i><\/a><\/td><\/tr>
2020.11.04<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended\u00a0October 31, 2020\u00a0 <\/td><\/i><\/a><\/td><\/tr>
2020.10.08<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended\u00a0September 30, 2020\u00a0 <\/td><\/i><\/a><\/td><\/tr>
2020.09.25<\/td>Change of Chief Financial Officer<\/td><\/i><\/a><\/td><\/tr>
2020.09.04<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended\u00a0August 31, 2020<\/td><\/i><\/a><\/td><\/tr>
2020.08.14<\/td>Date Of Board Meeting<\/td><\/i><\/a><\/td><\/tr>
2020.08.06<\/td>Supplemental Announcement In Relation To The Acquisition Of 100% Equity Interest In ACME BIOSCIENCE, INC.\u00a0 <\/td><\/i><\/a><\/td><\/tr>
2020.08.05<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended\u00a0July 31, 2020\u00a0 <\/td><\/i><\/a><\/td><\/tr>
2020.07.20<\/td>Announcement On The Proposed Listing Of The Controlling Shareholder On The Main Board Of The Stock Exchange Of Hong Kong Limited<\/td><\/i><\/a><\/td><\/tr>
2020.07.14<\/td>2019 Environmental, Social and Governance Report<\/td><\/i><\/a><\/td><\/tr>
2020.07.07<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended\u00a0June 30, 2020\u00a0 <\/td><\/i><\/a><\/td><\/tr>
2020.07.03<\/td>Discloseable Transaction Acquisition Of 100% Equity Interest In ACME BIOSCIENCE, INC.<\/td><\/i><\/a><\/td><\/tr>
2020.06.04<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended\u00a0May 31, 2020\u00a0<\/td><\/i><\/a><\/td><\/tr>
2020.05.28<\/td>Poll Results Of The Annual General Meeting Held On May 28, 2020\u00a0<\/td><\/i><\/a><\/td><\/tr>
2020.05.07<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended\u00a0April 30, 2020\u00a0 <\/td><\/i><\/a><\/td><\/tr>
2020.04.20<\/td>Announcements and Notices \u2013 [Notice of AGM]<\/td><\/i><\/a><\/td><\/tr>
2020.04.20<\/td>[Re-election or Appointment of Director subject to Shareholders\u2019 Approval \/ General Mandate \/ Explanatory Statement for Repurchase of Shares]<\/td><\/i><\/a><\/td><\/tr>
2020.04.20<\/td>Proxy Forms<\/td><\/i><\/a><\/td><\/tr>
2020.04.03<\/td>Issuer on Movements in Securities for the Month Ended\u00a0March 31, 2020\u00a0<\/td><\/i><\/a><\/td><\/tr>
2020.03.30<\/td>Announcement Of Annual Results For Year Ended December 31,2019<\/td><\/i><\/a><\/td><\/tr>
2020.03.17<\/td>Date Of Board Meeting<\/td><\/i><\/a><\/td><\/tr>
2020.03.05<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended\u00a0February 29, 2020\u00a0<\/td><\/i><\/a><\/td><\/tr>
2020.02.06<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended\u00a0January 31, 2020\u00a0 <\/td><\/i><\/a><\/td><\/tr>
2020.01.06<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended\u00a0December 31, 2019<\/td><\/i><\/a><\/td><\/tr>
2019.12.16<\/td>Voluntary Announcement-Acquisition Of BRI Biopharmaceutical Research,Inc.<\/td><\/i><\/a><\/td><\/tr>
2019.12.04<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended\u00a0November 30, 2019\u00a0<\/td><\/i><\/a><\/td><\/tr>
2019.11.05<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended\u00a0October 31, 2019<\/td><\/i><\/a><\/td><\/tr>
2019.11.04<\/td>Voluntary Announcement Acquisition Of RMI Laboratories,LLC<\/td><\/i><\/a><\/td><\/tr>
2019.10.25<\/td>Discloseable Transaction-Acquisition Of 25.96% Equity Interests In Frontage Laboratories(Suzhou)Co.,Ltd.<\/td><\/i><\/a><\/td><\/tr>
2019.10.08<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended\u00a0September 30, 2019<\/td><\/i><\/a><\/td><\/tr>
2019.09.04<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended August 31, 2019<\/td><\/i><\/a><\/td><\/tr>
2019.08.20<\/td>2019 Interim Results Announcement<\/td><\/i><\/a><\/td><\/tr>
2019.08.07<\/td>Date of Board Meeting<\/td><\/i><\/a><\/td><\/tr>
2019.08.05<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended July 31, 2019<\/td><\/i><\/a><\/td><\/tr>
2019.07.30<\/td>Positive Profit Alert<\/td><\/i><\/a><\/td><\/tr>
2019.07.04<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended June 30, 2019<\/td><\/i><\/a><\/td><\/tr>
2019.07.01<\/td>Sale of 45% Equity Interest In Tiger-Xinze Medical Technology (Jiaxing) Co., Ltd. to the Controlling Shareholder of Frontage Holdings Corporation<\/td><\/i><\/a><\/td><\/tr>
2019.07.01<\/td>Sale of 45% Equity Interest In Tigermed-BDM, Inc. to the Controlling Shareholder of Frontage Holdings Corporation<\/td><\/i><\/a><\/td><\/tr>
2019.06.27<\/td>Change of Address of Hong Kong Share Registrar and Transfer Office<\/td><\/i><\/a><\/td><\/tr>
2019.06.23<\/td>Stabilising Actions, End of Stabilisation Period and Lapse of Over-Allotment Option<\/td><\/i><\/a><\/td><\/tr>
2019.06.06<\/td>Monthly Return of Equity Issuer on Movements in Securities for the Month Ended May 31, 2019<\/td><\/i><\/a><\/td><\/tr>
2019.05.28<\/td>Procedures for Shareholders to Propose Persons for Election as Directors<\/td><\/i><\/a><\/td><\/tr>
2019.05.28<\/td>Terms of Reference of the Nomination Committee<\/td><\/i><\/a><\/td><\/tr>
2019.05.28<\/td>Terms of Reference of the Remuneration Committee<\/td><\/i><\/a><\/td><\/tr>
2019.05.28<\/td>Terms of Reference of the Audit and Risk Management Committee <\/td><\/i><\/a><\/td><\/tr>
2019.05.28<\/td>List of Directors and Their Roles and Functions<\/td><\/i><\/a><\/td><\/tr>
2019.05.28<\/td>Articles of Association<\/td><\/i><\/a><\/td><\/tr>
2019.05.28<\/td>Allotment Results Announcement<\/td><\/i><\/a><\/td><\/tr>
2019.05.17<\/td>Formal Notice [Global Offering]<\/td><\/i><\/a><\/td><\/tr>
2019.05.16<\/td>Mixed Media Offer<\/td><\/i><\/a><\/td><\/tr><\/tbody><\/table><\/em> <\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":32,"featured_media":0,"parent":1595,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-2436","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/frontagelab.com.cn\/en\/wp-json\/wp\/v2\/pages\/2436","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/frontagelab.com.cn\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/frontagelab.com.cn\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/frontagelab.com.cn\/en\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/frontagelab.com.cn\/en\/wp-json\/wp\/v2\/comments?post=2436"}],"version-history":[{"count":1,"href":"https:\/\/frontagelab.com.cn\/en\/wp-json\/wp\/v2\/pages\/2436\/revisions"}],"predecessor-version":[{"id":10412,"href":"https:\/\/frontagelab.com.cn\/en\/wp-json\/wp\/v2\/pages\/2436\/revisions\/10412"}],"up":[{"embeddable":true,"href":"https:\/\/frontagelab.com.cn\/en\/wp-json\/wp\/v2\/pages\/1595"}],"wp:attachment":[{"href":"https:\/\/frontagelab.com.cn\/en\/wp-json\/wp\/v2\/media?parent=2436"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}